Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services (NCT04738825)
🩺 Plain-English Summary (8th-Grade Level)
The proposed study will be a 24-week intervention with a 12-month follow-up period to evaluate the impact of contingency management with stepped care to pre-exposure prophylaxis (PrEP) adherence and support services (CoMPASS) to promote HIV prevention among individuals with opioid use disorder who have injected drugs in their lifetime. In parallel, the investigators will conduct an implementation focused process evaluation to inform real-world implementation of CoMPASS. .
Who can join: Review the eligibility criteria below.
Location: Recovery Network of Programs, Inc — Bridgeport, Connecticut
Age range: 18 Years
🧪 Interventions in This Study
- Contingency Management with stepped care to PrEP adherence and support services (CoMPASS) (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Recovery Network of Programs, Inc — Bridgeport, Connecticut
- Liberations Program, Inc — Bridgeport, Connecticut
- Apex Community Care. Inc. — Danbury, Connecticut
- Connecticut Harm Reduction Alliance (GHHRC and SWAN) — New Haven, Connecticut
- The APT Foundation (Legion and Long Wharf) — New Haven, Connecticut
- Stanley Street Treatment and Resource Center — Fall River, Massachusetts
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid-use Disorder
- Recovery Management Checkups for Opioid Use Disorder Experiment — Chicago, Illinois
- Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder — Philadelphia, Pennsylvania
- Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment — The Bronx, New York
- Neuromodulation and Cognitive Training in Opioid Use Disorder — Minneapolis, Minnesota
- Pilot Research on Opioid Use Disorder — San Francisco, California
Explore by condition: All Opioid-use Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.